Page last updated: 2024-08-25

ethyl 3-amino-1h-pyrazole-4-carboxylate and cyclic nucleotide phosphodiesterases, type 4

ethyl 3-amino-1h-pyrazole-4-carboxylate has been researched along with cyclic nucleotide phosphodiesterases, type 4 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artis, DR; Blasdel, L; Bollag, G; Card, GL; England, BP; Fong, D; Gillette, S; Ibrahim, PN; Kim, SH; Milburn, MV; Schlessinger, J; Suzuki, Y; Zhang, C; Zhang, KY1

Other Studies

1 other study(ies) available for ethyl 3-amino-1h-pyrazole-4-carboxylate and cyclic nucleotide phosphodiesterases, type 4

ArticleYear
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design.
    Nature biotechnology, 2005, Volume: 23, Issue:2

    Topics: Binding Sites; Crystallography; Drug Delivery Systems; Drug Design; Peptide Fragments; Peptide Library; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Binding; Protein Interaction Mapping

2005